Delivery Order SPE2DR25D2014-SPE2DR26FA4H4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for ACT-O-VIALS on February 3, 2026, with a completion date of February 4, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s, larger Indefinite...
- The Defense Logistics Agency awarded a $5,618.20 delivery order to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 14, 2026, with completion expected by January 15, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 20, 2026, with an ultimate completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under full and open competition. The contractor, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government healthcare systems....
- The Defense Logistics Agency awarded a delivery order valued at $12,228.81 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,275.21 to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 21, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's parent company Cencora, Inc., and carries no set-aside designation. The contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for ACT-O-VIALS, with an ultimate completion date of January 14, 2026. This is a firm fixed-price delivery order issued under a competitive process with no set-aside designation. The awardee, AmerisourceBergen Drug Corp, is headquartered in Conshohocken, Pennsylvania, and serves as a critical pharmaceutical distributor to federal medical procurement programs, particularly...
- The Defense Logistics Agency awarded a $6,641.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ACT-O-VIALS, with an ultimate completion date of November 28, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $2,850.14 to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 30, 2026, with an ultimate completion date of February 2, 2026. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $9,298.24 firm fixed price delivery order to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 22, 2025, with completion targeted for December 23, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,969.92 to AmerisourceBergen Drug Corp for ACT-O-VIALS on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The contract performs at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA4H4Delivery Order
The Defense Logistics Agency awarded a $4,318.61 delivery order to AmerisourceBergen Drug Corp for ACT-O-VIALS on February 3, 2026, with completion expected by February 4, 2026. This non-set-aside, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and extending through December 2026. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for vials represents one of numerous task orders supporting DLA's pharmaceutical supply chain operations for military treatment facilities and federal healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 2/2/26 |